成人和青少年患有埃索诺菲尔食道炎的Cendakimab
Evan S Dellon1, Christina M Charriez2, Sandra Zhang2
1Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill.
NEJM evidence
|September 23, 2025
概括
仙达基马布显著改善了酸性食道炎 (EoE) 患者的症状和组织学反应. 这种向介素-13 (IL-13) 治疗在第三阶段试验中显示出良好的安全性.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 临床试验 临床试验
背景情况:
- 生性食道炎 (EoE) 是一种慢性食道疾病,其特征是2型炎症.
- 互白素-13 (IL-13) 是EoE病变发生的一个关键驱动因素.
- 仙达基马布是一种单克隆抗体,旨在阻止IL-13信号传递.
研究的目的:
- 评估 cendakimab 在患有 EoE 的成人和青少年患者的疗效和安全性.
- 评估仙达基马布对食障碍,组织学特征和内镜发现的影响.
主要方法:
- 一项3期随机试验,涉及430名12至75岁的EoE患者.
- 患者接受了仙达基马布 (360毫克每周或每周一次,然后每隔一周一次) 或安慰剂48周.
- 在第24周的共同初级终点包括消化不良天的变化和食道氨基酸细胞计数的峰值.
主要成果:
- 与安慰剂相比,Cendakimab显著减少了24周的消化不良日和改善了24周的组织学反应 (P<0.001).
- 随着仙达基马布治疗,内镜严重性也得到改善.
- 疗效维持到第48周,治疗组的不良事件率在治疗组之间相似.
结论:
- 仙达基马布在EoE症状,组织学和内镜特征上显示出了统计学上显著的改善.
- 仙达基马布的安全性和耐受性概况并没有限制剂量.
- 仙达基马布代表了一种有前途的治疗选择,用于治疗异性食道炎.
更多相关视频
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:21Barrett Esophagus-II: Clinical Manifestations and Management
802
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
802
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
705
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
705
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
589
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
589